Oaktree Capital Management Incoming Co-CEO Armen Panossian speaks with Bloomberg's Katie Greifeld about the markets. 

Oaktree Capital Management Incoming Co-CEO Armen Panossian speaks with Bloomberg's Katie Greifeld about the markets.

Listen for top interviews from Bloomberg News. 

Hear conversations with the biggest names in finance, politics, technology, foreign relations, sports and entertainment.

Listen for top interviews from Bloomberg News. Hear conversations with the biggest names in finance, politics, technology, foreign relations, sports and entertainment.

Listen to top interviews from Bloomberg News.

Bloomberg Talks

Oaktree Incoming Co-CEO Armen Panossian Talks Markets

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/d4eb61ed-3716-4bef-85ae-b03101314fec/transcript

Doug Irwin, Professor of Economics at Dartmouth, discusses the latest developments on President Trump's unfolding tariff strategy and their broader economic impact. He speaks with Bloomberg's Tom Keene and Paul Sweeney

Doug Irwin, Professor of Economics at Dartmouth, discusses the latest developments on President Trump's unfolding tariff strategy and their broader economic impact. He speaks with Bloomberg's Tom Keene and Paul Sweeney

Dartmouth's Douglas Irwin Talks Blanket Tariffs

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/bbc3ccb4-7604-4484-8984-b3fb00ffdb5e/transcript

Federal Reserve Bank of Chicago President Austan Goolsbee says he is more concerned about inflation amid a "steady" job market. Speaking with Bloomberg's Mike McKee, Goolsbee also comments on what the tariff ruling could mean for inflation and Fed Chair Jerome Powell possibly staying on the central bank's board.

Federal Reserve Bank of Chicago President Austan Goolsbee says he is more concerned about inflation amid a "steady" job market. Speaking with Bloomberg's Mike McKee, Goolsbee also comments on what the tariff ruling could mean for inflation and Fed Chair Jerome Powell possibly staying on the central bank's board.

Austin Goolsbee Talks Inflation Risk, Tariffs, Powell

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/f5a81e9c-f2c1-44b9-afbf-b3fb00ffd4d8/transcript

Novo Nordisk Chief Scientific Officer Martin Holst Lange discusses the recent clinical trial results of the company's weight loss obesity shot CagriSema, which delivered less weight loss than Eli Lilly’s tirzepatide. Holst Lange also outlines Novo Nordisk's broader obesity treatment pipeline. He speaks with Bloomberg's Dani Burger. 

Novo Nordisk Chief Scientific Officer Martin Holst Lange discusses the recent clinical trial results of the company's weight loss obesity shot CagriSema, which delivered less weight loss than Eli Lilly&rsquo;s tirzepatide. Holst Lange also outlines Novo Nordisk's broader obesity treatment pipeline. He speaks with Bloomberg's Dani Burger.&nbsp;

Novo's Martin Holst Lange Talks New Weight Loss Shot

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/55950a5c-8908-4f1c-a819-b3fa01192054/transcript

Oaktree Incoming Co-CEO Armen Panossian Talks Markets

In 1 playlist(s)

Bloomberg Talks

Social links

Follow podcast

Recent clips